Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

57.04
Delayed Data
As of Dec 09
 +1.81 / +3.28%
Today’s Change
49.03
Today|||52-Week Range
77.12
-17.08%
Year-to-Date
The 3 Fastest-Growing Drug Classes Over the Next 5 Years
11:44am / MotleyFool.com - Paid Partner Content
3 Beaten-Up Healthcare Stocks: Are They Bargains?
Dec 06 / MotleyFool.com - Paid Partner Content
Will Stock No Longer Be Bristol-Mired?
Dec 09 / TheStreet.com - Paid Partner Content
Why Exelixis Was a Top Stock in 2016 So Far
Dec 02 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Drug Pricing Heat Back on Sector, Endo, Mylan, AZN to Cut Jobs
Dec 09 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
Dec 02 / Zacks.com - Paid Partner Content
Why AstraZeneca plc Stock Slumped in November
Dec 07 / MotleyFool.com - Paid Partner Content
Heat Biologics Stock Falls on Negative Bladder Cancer Data
Dec 01 / Zacks.com - Paid Partner Content
Bristol-Myers Reports Data from Opdivo Combination Studies
Dec 06 / Zacks.com - Paid Partner Content
3 Ways Organovo Holdings, Inc. Plans to Grow Exponentially for Years to Come
Dec 01 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close55.23
Today’s open55.16
Day’s range55.10 - 57.18
Volume11,782,750
Average volume (3 months)14,000,058
Market cap$95.3B
Dividend yield2.66%
Data as of 4:02pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-22.50%
Earnings growth (this year)+42.31%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+4.29%
P/E ratio28.5
Price/Sales6.97
Price/Book6.64

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.40+1.07%
ABBVAbbVie+0.64+1.05%
CELGCelgene+0.41+0.36%
SNYSanofi+0.63+1.58%
Data as of 4:14pm ET, 12/09/2016

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$0.66
Annual revenue (last year)$16.6B
Annual profit (last year)$1.6B
Net profit margin9.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts


Search for Jobs